Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy
Sarah Spiegel, Sheldon Milstien, Steven Grant
Oncogene (2011) Vol. 31, Iss. 5, pp. 537-551
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
Patrício Godoy, Nicola J. Hewitt, Ute Albrecht, et al.
Archives of Toxicology (2013) Vol. 87, Iss. 8, pp. 1315-1530
Open Access | Times Cited: 1188
Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
Amila Suraweera, Kenneth J. O’Byrne, Derek J. Richard
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 589
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
Mercedes Lobera, Kevin P. Madauss, Denise Teotico Pohlhaus, et al.
Nature Chemical Biology (2013) Vol. 9, Iss. 5, pp. 319-325
Closed Access | Times Cited: 337
Combined autophagy and HDAC inhibition
Devalingam Mahalingam, Monica Mita, John Sarantopoulos, et al.
Autophagy (2014) Vol. 10, Iss. 8, pp. 1403-1414
Open Access | Times Cited: 268
Epigenetic treatment of solid tumours: a review of clinical trials
Clara Nervi, Elisabetta De Marinis, Giovanni Codacci-Pisanelli
Clinical Epigenetics (2015) Vol. 7, Iss. 1
Open Access | Times Cited: 195
Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia
Brenton G. Mar, Lars Bullinger, Kathleen M. McLean, et al.
Nature Communications (2014) Vol. 5, Iss. 1
Open Access | Times Cited: 189
Mitochondria in cancer
Debora Grasso, Luca X. Zampieri, Tânia Capelôa, et al.
Cell Stress (2020) Vol. 4, Iss. 6, pp. 114-146
Open Access | Times Cited: 181
Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis
Tamara Pérez-Jeldres, Manuel Álvarez-Lobos, Jesús Rivera–Nieves
Drugs (2021) Vol. 81, Iss. 9, pp. 985-1002
Open Access | Times Cited: 143
Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair
Blaž Grošelj, Nitin Sharma, Freddie C. Hamdy, et al.
British Journal of Cancer (2013) Vol. 108, Iss. 4, pp. 748-754
Open Access | Times Cited: 177
Chromatin remodeling — a novel strategy to control excessive alcohol drinking
Vincent Warnault, Emmanuel Darcq, Amir Levine, et al.
Translational Psychiatry (2013) Vol. 3, Iss. 2, pp. e231-e231
Open Access | Times Cited: 153
Development and therapeutic impact of HDAC6-selective inhibitors
Sabrina Dallavalle, Claudio Pisano, Franco Zunino
Biochemical Pharmacology (2012) Vol. 84, Iss. 6, pp. 756-765
Closed Access | Times Cited: 135
Targeting histone deacetylase 6 mediates a dual anti‐melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
Karrune Woan, Maritza Lienlaf, P. Perez-Villaroel, et al.
Molecular Oncology (2015) Vol. 9, Iss. 7, pp. 1447-1457
Open Access | Times Cited: 128
Health Promoting Effects of Brassica-Derived Phytochemicals: From Chemopreventive and Anti-Inflammatory Activities to Epigenetic Regulation
Anika E. Wagner, Anna Maria Terschluesen, Gerald Rimbach
Oxidative Medicine and Cellular Longevity (2013) Vol. 2013, pp. 1-12
Open Access | Times Cited: 121
The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer
Nitai C. Hait, Dorit Avni, Akimitsu Yamada, et al.
Oncogenesis (2015) Vol. 4, Iss. 6, pp. e156-e156
Open Access | Times Cited: 95
Tamoxifen Action in ER-Negative Breast Cancer
Subrata Manna, Marina K. Holz
Signal Transduction Insights (2016) Vol. 5, pp. STI.S29901-STI.S29901
Open Access | Times Cited: 87
Sphingosine-1-Phosphate Signaling in Cardiovascular Diseases
Na Wang, Jingyi Li, Bo Zeng, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 818-818
Open Access | Times Cited: 24
Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration
Silvio Danese, Federica Furfaro, Stefania Vetrano
Journal of Crohn s and Colitis (2017) Vol. 12, Iss. suppl_2, pp. S678-S686
Open Access | Times Cited: 83
p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors
Jürgen Sonnemann, Christian Marx, Jonathan Becker, et al.
British Journal of Cancer (2013) Vol. 110, Iss. 3, pp. 656-667
Open Access | Times Cited: 80
HDAC Inhibitors Augmented Cell Migration and Metastasis through Induction of PKCs Leading to Identification of Low Toxicity Modalities for Combination Cancer Therapy
Kuen‐Tyng Lin, Yiwei Wang, Chiung‐Tong Chen, et al.
Clinical Cancer Research (2012) Vol. 18, Iss. 17, pp. 4691-4701
Open Access | Times Cited: 80
HDAC8 substrates: Histones and beyond
Noah A. Wolfson, Carol Ann Pitcairn, Carol A. Fierke
Biopolymers (2012) Vol. 99, Iss. 2, pp. 112-126
Open Access | Times Cited: 79
Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells
Anderly C. Chüeh, Janson W.T. Tse, Lars Tögel, et al.
Antioxidants and Redox Signaling (2014) Vol. 23, Iss. 1, pp. 66-84
Open Access | Times Cited: 74
Truth and consequences of sphingosine-1-phosphate lyase
Ana García Aguilar, Julie D. Saba
Advances in Biological Regulation (2011) Vol. 52, Iss. 1, pp. 17-30
Open Access | Times Cited: 76
Ethanol Induces Epigenetic Modulation of Prodynorphin and Pronociceptin Gene Expression in the Rat Amygdala Complex
Claudio D’Addario, Francesca Felicia Caputi, Tomas J. Ekström, et al.
Journal of Molecular Neuroscience (2012) Vol. 49, Iss. 2, pp. 312-319
Closed Access | Times Cited: 74
Targeting class I histone deacetylases in cancer therapy
Geneviève P. Delcuve, Dilshad H. Khan, James Davie
Expert Opinion on Therapeutic Targets (2012) Vol. 17, Iss. 1, pp. 29-41
Closed Access | Times Cited: 64
The role of hypoxia in pulmonary vascular diseases: a perspective
Norbert F. Voelkel, Shiro Mizuno, Harm Jan Bogaard
AJP Lung Cellular and Molecular Physiology (2013) Vol. 304, Iss. 7, pp. L457-L465
Closed Access | Times Cited: 63
Page 1 - Next Page

Scroll to top